Home / Biotechnology / Microbiome

Microbiome Sequencing Services Market By Research (Outsourced, In-house), By Technology (Shotgun, Targeted Gene, RNA And Whole Genome Sequencing, Others), By Application (Therapeutics, Genetic Screening, Drug and Biomarker Discovery, Personalized Medicine, Others), By End User (Pharmaceutical and Biotechnology Companies, Research and Academia Institutes, Others) - Growth, Future Prospects And Competitive Analysis, 2017 - 2025

The human body harbors around 100 trillion microbial organisms throughout body known as the microbiota, and the genomes of all the microflora is known as microbiome. These microorganisms play a significant role in human health, including metabolism and immunity. Any alteration in composition of microbiome can lead to disease such as ulcerative colitis, irritable bowel syndrome, Crohn’s disease, psoriasis, asthma and cardiovascular diseases. Major focus is on studying the gut microbes in diagnostics, as there is observed alteration in types of microbes at times of inflammatory bowel diseases such as Crohn’s disease or ulcerative colitis. Thus microbiome sequencing helps in understanding of wide range of diseases and ailments and further treating them. There is being rise in funding of microbiome companies, start-ups, research-based companies that amass knowledge and data for potential partnerships with pharmaceutical firms. With advancement of technology in genomics and microflora, microbiome-based therapeutics are evolving towards personalized medicine. Thus potential growth is expected to be exhibited by the microbiome sequencing services market. Microbiome sequencing services have paved new roadmap towards the disease prevention and management.

The report titled “Microbiome Sequencing Services Market - Growth, Future Prospects and Competitive Analysis, 2017–2025” offers strategic insights into the overall microbiome sequencing services market along with the market size and estimates for the duration 2015 to 2025. The said research study covers in-depth analysis of multiple market segments based on type of technology, application, research, end users and different geographies. The technology types studied for analyzing the overall global microbiome sequencing services market are majorly segmented into shotgun sequencing, targeted gene sequencing, RNA sequencing, whole genome sequencing and others. The global microbiome sequencing services market is segmented by application type into therapeutics, genetic screening, drug and biomarker discovery, personalised medicine and others. By research type, the global microbiome sequencing services market is segmented into outsourced and in-house. It is further segmented into end users into pharmaceutical and biotechnology companies, academia/research institutes and others.

Geographically, the global microbiome sequencing services market is studied for the following regional markets:

North America
U.S.
Canada
Europe
U.K.
Germany
Rest of Europe
Asia Pacific
China
Japan
Rest of Asia Pacific
Latin America
Brazil
Mexico
Rest of Latin America
Middle East and Africa
GCC
Rest of Middle East and Africa

Market size and forecast for these regional and country level markets are presented in this study for the period 2015-2025. Market growth rates for the forecast period 2017-2025 are also included in this report, considering 2016 as the base year. Further cross-sectional presented in terms of technology, application, research, end users and constituent region/country level markets is also included in this section.

Along with quantitative information, qualitative information sets and assessment tools are provided in this study for better analysis of the overall market scenario and future prospects. Information such as market drivers, challenges and opportunities assists the readers for understanding the ongoing trends in the global microbiome sequencing services market. Tools such as market positioning of key players and attractive investment proposition provide the readers with insights on the competitive scenario of the global microbiome sequencing services market. This report concludes with company profiles section that highlights major information about the key players engaged in global microbiome sequencing services market. In-depth competitive environment analysis and historical (2015) market size data are also provided in the report.

Furthermore, this report concludes with profiling of key market players currently enjoying prominent position in the vascular grafts market. The key players profiled in this report are Baseclear B.V., Clinical-Microbiomics A/S, Diversigen, Inc., Merieux Nutrisciences Corporation, Metabiomics Corp., Microbiome Therapeutics, LLC, Microbiome Insights, Inc., Molzym GmbH & Co. Kg, MR DNA (Molecular Research Lp), Openbiome, Shanghai Realbio Technology Co., Ltd, Rancho Biosciences, Resphera Biosciences, LLC, Ubiome, Inc., Zymo Research Corp. and others.

Microbiome Sequencing Services Market

Based on the type of application, the global microbiome sequencing services market is segmented as follows: 

  • Therapeutics
    • Oncology
    • Idiopathic Diseases
    • Infectious Diseases
  • Genetic Screening
  • Drug and Biomarker Discovery
  • Personalized Medicine
  • Others 

Human microbiome sequencing focuses on widespread research interest in treating number of diseases. There is vigorous research and development on association of microbiome alteration and diseases and further studying the widespread network of interactions that affect the immune system, neurology human metabolism and skin. Microflora plays important role in different areas of health such as hygiene, infectious disease and chronic health diseases. Dysbiosis in gut is responsible for a wide range of conditions such as irritable bowel syndrome or as Crohn’s diseases or ulcerative colitis, asthma, psoriasis, cancer, obesity, diabetes, neurological disorders and even cardiovascular diseases. Thus therapeutics application play a significant role in microbiome market, occupying major share and dominating the microbiome sequencing service market. Major driving factor for the growth of therapeutic segment in microbiome sequencing service market is rise in prevalence of cancer, infectious disease. Rise in funding by government and pharmaceutical companies in drug discovery and development and personalised medicine would exhibit fast growth in this segment of microbiome sequencing service market.

Microbiome Sequencing Services Market

Based on the type of end users, the global microbiome sequencing services market is segmented as follows: 

  • Pharmaceutical and Biotechnology Companies
  • Research and Academia Institutes
  • Others 

Pharmaceutical and biotechnology companies segment dominates global microbiome sequencing services market and is anticipated to have highest CAGR in the forecast period. There is a significant rise in funding of microbiome companies and start-ups. Similar rise is also observed in venture-capital investment in microbiome companies that has grown at steady pace when compared with other areas of investment by venture capital firms. Thus increase in government funding or venture capitalist to boost research and development in drug discovery and development will in turn enhance microbiome sequencing services market.

Microbiome Sequencing Services Market

For the purpose of this study, the global microbiome sequencing services market is geographically categorized into:

  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • France
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • Rest of Asia
  • Latin America
    • Brazil
    • Rest of Latin America
  • Middle East and Africa
    • GCC
    • Rest of Middle East and Africa

 

Microbiome Sequencing Services Market

In 2016, North America dominated the global microbiome sequencing services market followed by Europe. High throughput sequencing studies and new software tools are revolutionizing the microbial analyses study in developed regions. Major factors such as overall advancement in genome technology, rise in government funding for genomics research, availability of next generation sequencing for data analyses. Growing interest in microbiome sequencing for exploring personalized medicine and disease prevention and treatment is one of the key factors driving the growth of microbiome sequencing services market along with evolving sequencing technology. Government and pharmaceutical companies funding in research and development for drug discovery and development and genome screening and analyses is plays important role in boosting the growth of microbiome sequencing services market in North America and Europe. Asia Pacific is anticipated to be the fastest growing regional market in the forecast period 2017-2025. Rise in prevalence of diseases such as cancer, infectious disease, increasing investment for development of healthcare and rising awareness about, medical awareness among population and evolving sequencing technology are some of the major reason of growth of microbiome sequencing services market.

Choose License Type
Published Date:  Aug 2017
Category:  Biotechnology
Report ID:   58642
Report Format:   PDF
Pages:   120
Rating:    4.3 (50)
Connect With Us
+1-408-641-3282
24/7 Research Support